OPTIONS (Details) - $ / shares	6 Months Ended
OPTIONS (Details) - $ / shares	Mar. 31, 2022	Mar. 31, 2021	Sep. 30, 2021
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	3,291,000		3,291,000
Employee
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number	2,916,000		2,916,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price	$ 0.0067		$ 0.0067
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term	1 year 11 months 12 days	1 year 11 months 12 days
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number	2,916,000		2,916,000
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price	$ 0.0067		$ 0.0067
Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Remaining Contractual Term	1 year 11 months 12 days	1 year 11 months 12 days

PEAK PHARMACEUTICALS, INC. 10-Q